Neurobiological Technologies (Neurobiological Technologies) Debt-to-Asset : 0.00 (As of Sep. 2009)

Neurobiological Technologies Debt-to-Asset Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
Debt-to-Asset		Get a 7-Day Free Trial					-	-	-	-	-

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
Debt-to-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Neurobiological Technologies's Debt-to-Asset

For the Biotechnology subindustry, Neurobiological Technologies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Debt-to-Asset falls into.

Neurobiological Technologies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Neurobiological Technologies's Debt-to-Asset for the fiscal year that ended in Jun. 2009 is calculated as

Neurobiological Technologies's Debt-to-Asset for the quarter that ended in Sep. 2009 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Neurobiological Technologies Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description